Pharmacological properties of centrally administered ouabain and their modification by other drugs

British Journal of Pharmacology
N S Doggett, P S Spencer

Abstract

1. Ouabain given by intracerebroventricular injection to mice in small doses (0.1-0.4 mug) produced a dose related depression of central nervous activity, characterized by a reduction in spontaneous locomotor activity, hypothermia, catalepsy and ptosis, lowered body posture and lack of response to external stimuli. Doses above 0.4 mug were excitatory, convulsant and lethal.2. The depressant effects could be antagonized by (+)-amphetamine, desmethylimipramine, dibutyryl cyclic 3'5'-adenosine monophosphate and caffeine.3. The MAO inhibitor nialamide produced only a small antagonism of ouabain, resulting in a greater rate of recovery from the depressant effects of ouabain.4. The depressant effects were associated with a marked elevation of whole-brain dopamine levels with little change in noradrenaline or 5-hydroxytryptamine.5. The dopamine-beta-hydroxylase inhibitor sodium diethyldithiocarbamate, administered by intracerebroventricular injection, produced effects qualitatively similar to those seen after ouabain.6. An interference with central transmitter function is postulated as a possible mode of action of intracerebroventricularly injected ouabain.

References

Feb 21, 1970·Lancet·Y H Abdulla, K Hamadah
Nov 1, 1967·Biochemical Pharmacology·F Berti, P A Shore
Feb 1, 1970·European Journal of Pharmacology·M S Ebadi, M J Carver
Jan 1, 1966·The Journal of Pharmacy and Pharmacology·A CarlssonT Hökfelt
Aug 1, 1968·The Journal of Pharmacy and Pharmacology·A Barnett, R I Taber
Dec 1, 1968·The Journal of Pharmacy and Pharmacology·T Persson, B Waldeck
Sep 1, 1970·Toxicology and Applied Pharmacology·G G Buterbaugh, J L Spratt
Aug 1, 1967·Life Sciences·K J BlackburnR J Merrills
Jan 1, 1970·Acta Pharmacologica Et Toxicologica·K Hermansen
Mar 1, 1957·British Journal of Pharmacology and Chemotherapy·T J HALEY, W G MCCORMICK
Dec 1, 1962·The Journal of Pharmacy and Pharmacology·C H CASHIN, H JACKSON
Jul 1, 1964·The Journal of Pharmacy and Pharmacology·R T BRITTAIN, P S SPENCER

❮ Previous
Next ❯

Citations

Jan 1, 1973·Journal of Neural Transmission·W Ladisich
Jan 1, 1982·Pharmacology & Therapeutics·K O Haustein
Jan 1, 1990·Comparative Biochemistry and Physiology. A, Comparative Physiology·A A MakiK M Eskridge
Dec 31, 2002·European Journal of Pharmacology·Gyöngyi HorvathJose Manuel Baeyens
May 1, 1985·Journal of the American College of Cardiology·J C Longhurst, J Ross
Nov 1, 1980·British Journal of Pharmacology·M J DascombeR G Pertwee
Jun 30, 1972·Nature·N S Doggett, P S Spencer
Mar 15, 1978·Biochemical Pharmacology·R A GillisJ A Quest

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.